HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

BCPC

Balchem Corporation (NASDAQ)

Basic Materials — Specialty Chemicals

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

None 4 analysts
$162.10
+$0.98 (+0.61%)
Target: $200.75 (23.8%)
Sign in to add BCPC to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$5.43B
P/E Ratio (TTM)34.75
Forward P/E27.64
EPS (TTM)$4.86
Dividend Yield0.57%
Profit Margin14.95%
Revenue Growth8.10%
ROE12.68%
Debt/Equity14.37
Recommendation None
Analyst Target$200.75
Analysts4
Indexes NASDAQ

Technical Indicators

RSI (14)72.6
Beta0.83
SMA 20-
SMA 40-
52-Week High$183.90
52-Week Low$139.17
50-Day Avg$164.10
200-Day Avg$162.13
Avg Volume230.8K
Volume146.4K

Performance Analysis

NEUTRAL

BCPC presents a mixed picture with both positive and negative indicators.

~ Trading at 51% of its 52-week range.
- RSI at 72.6 indicates overbought conditions — a pullback may be due.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 8.1% year-over-year.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $200.75 implies 23.8% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 12:59 UTC

Back to Screener Export Report